Broadcom
AVGO
Alibaba
BABA
NVIDIA
NVDA
Taiwan Semiconductor
TSM
Meta Platforms
META
US Stock MarketDetailed Quotes
SWTX SpringWorks Therapeutics
- 54.140
- +0.110+0.20%
Close Feb 26 16:00 ET
- 55.000
- +0.860+1.59%
Pre 05:04 ET
4.06BMarket Cap-15.56P/E (TTM)
55.890High54.120Low1.16MVolume54.890Open54.030Pre Close63.68MTurnover1.58%Turnover RatioLossP/E (Static)74.94MShares62.00052wk High8.43P/B3.99BFloat Cap28.21052wk Low--Dividend TTM73.69MShs Float96.480Historical High--Div YieldTTM3.28%Amplitude13.600Historical Low54.783Avg Price1Lot Size
SpringWorks Therapeutics News
J.P. Morgan Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating, Announces Target Price $70
J.P. Morgan Sticks to Its Buy Rating for Springworks Therapeutics (SWTX)
H.C. Wainwright Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating, Maintains Target Price $74
Guggenheim Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating, Cuts Target Price to $77
SpringWorks Therapeutics Analyst Ratings
H.C. Wainwright Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating, Maintains Target Price $74
A Quick Look at Today's Ratings for SpringWorks Therapeutics(SWTX.US), With a Forecast Between $63 to $87
Analysts Are Bullish on These Healthcare Stocks: Aura Biosciences Inc (AURA), Springworks Therapeutics (SWTX)
BofA Securities Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating, Raises Target Price to $87
Evercore Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating, Raises Target Price to $65
Wedbush Adjusts Price Target on Springworks Therapeutics to $81 From $77, Maintains Outperform Rating
TD Cowen Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating, Maintains Target Price $66
SpringWorks Therapeutics Is Maintained at Outperform by Evercore ISI Group
SpringWorks Therapeutics Price Target Raised to $65.00/Share From $60.00 by Evercore ISI Group
SpringWorks Therapeutics Analyst Ratings
H.C. Wainwright Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating, Maintains Target Price $74
Buy Rating for Springworks Therapeutics Boosted by FDA Approval of GOMEKLI and Strong Market Potential
TD Cowen Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating, Raises Target Price to $66
Evercore Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating, Maintains Target Price $60
Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT) and Springworks Therapeutics (SWTX)
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.